Head and Neck Paraganglioma (HNPGL) Registry: A study protocol for prospective data collection in patients with Head and Neck Paragangliomas.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 25 01 2024
accepted: 02 07 2024
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 25 7 2024
Statut: epublish

Résumé

There is a lack of comprehensive and uniform data on head and neck paragangliomas (HNPGLs), and research is challenging due to its rarity and the involvement of multiple medical specialties. To improve current research data collection, we initiated the Head and Neck Paraganglioma Registry (HNPGL Registry). The aim of the HNPGL Registry is to a) collect extensive data on all HNPGL patients through a predefined protocol, b) give insight in the long term outcomes using patient reported outcome measures (PROMs), c) create uniformity in the diagnostic and clinical management of these conditions, and thereby d) help provide content for future (randomized) research. The HNPGL Registry is designed as a prospective longitudinal observational registry for data collection on HNPGL patients and carriers of (likely) pathogenic variants causative of HNPGLs. All patients, regardless of the received treatment modality, can be included in the registry after informed consent is obtained. All relevant data regarding the initial presentation, diagnostics, treatment, and follow-up will be collected prospectively in an electronic case report form. In addition a survey containing the EuroQol 5D-5L (EQ-5D-5L), European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), Modified Fatigue Impact Scale (MFIS), Short QUestionnaire to Assess Health-enhancing physical activity (SQUASH), Cancer Worry Scale (CWS) and Hospital Anxiety and Depression Scale (HADS) will be sent periodically. The registry protocol was approved by the Medical Ethical Review Board of the University Medical Center Utrecht. The HNPGL Registry data will be used to further establish the optimal management for HNPGL patients and lay the foundation for guideline recommendations and the outline of future research.

Identifiants

pubmed: 39052568
doi: 10.1371/journal.pone.0307311
pii: PONE-D-23-41008
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0307311

Informations de copyright

Copyright: © 2024 de Bresser et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

NO authors have competing interests

Auteurs

Carolijn J M de Bresser (CJM)

Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Bernadette P M van Nesselrooij (BPM)

Department of Clinical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.

Mark J C van Treijen (MJC)

Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.

Arthur J A T Braat (AJAT)

Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Mischa de Ridder (M)

Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands.

Robert J Stokroos (RJ)

Department of Otolaryngology-Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Remco de Bree (R)

Department of Otolaryngology-Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.

Gert J de Borst (GJ)

Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Johannes A Rijken (JA)

Department of Otolaryngology-Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.

Bart-Jeroen Petri (BJ)

Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH